Compile Data Set for Download or QSAR
Report error Found 61 Enz. Inhib. hit(s) with all data for entry = 7594
TargetProstaglandin E2 receptor EP2 subtype(Human)
Fovea Pharmaceuticals

US Patent
LigandPNGBDBM204980(US9249085, I(an))
Affinity DataEC50:  9nMAssay Description:Human CHO cells expressing the recombinant human prostanoid EP2 receptor were suspended in assay medium (HBSS buffer (Invitrogen) containing 20 mM HE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/12/2016
Entry Details
Go to US Patent

TargetProstaglandin E2 receptor EP2 subtype(Human)
Fovea Pharmaceuticals

US Patent
LigandPNGBDBM204968(US9249085, I(ab))
Affinity DataEC50:  50nMAssay Description:Human CHO cells expressing the recombinant human prostanoid EP2 receptor were suspended in assay medium (HBSS buffer (Invitrogen) containing 20 mM HE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/12/2016
Entry Details
Go to US Patent

TargetProstaglandin E2 receptor EP2 subtype(Human)
Fovea Pharmaceuticals

US Patent
LigandPNGBDBM204969(US9249085, I(ac))
Affinity DataEC50:  18nMAssay Description:Human CHO cells expressing the recombinant human prostanoid EP2 receptor were suspended in assay medium (HBSS buffer (Invitrogen) containing 20 mM HE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/12/2016
Entry Details
Go to US Patent

TargetProstaglandin E2 receptor EP2 subtype(Human)
Fovea Pharmaceuticals

US Patent
LigandPNGBDBM204970(US9249085, I(ad) | US9624159, Compound I(ad))
Affinity DataEC50:  2nMAssay Description:Human CHO cells expressing the recombinant human prostanoid EP2 receptor were suspended in assay medium (HBSS buffer (Invitrogen) containing 20 mM HE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/12/2016
Entry Details
Go to US Patent

TargetProstaglandin E2 receptor EP2 subtype(Human)
Fovea Pharmaceuticals

US Patent
LigandPNGBDBM204971(US9249085, I(ae))
Affinity DataEC50:  3nMAssay Description:Human CHO cells expressing the recombinant human prostanoid EP2 receptor were suspended in assay medium (HBSS buffer (Invitrogen) containing 20 mM HE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/12/2016
Entry Details
Go to US Patent

TargetProstaglandin E2 receptor EP2 subtype(Human)
Fovea Pharmaceuticals

US Patent
LigandPNGBDBM204972(US9249085, I(af))
Affinity DataEC50:  5nMAssay Description:Human CHO cells expressing the recombinant human prostanoid EP2 receptor were suspended in assay medium (HBSS buffer (Invitrogen) containing 20 mM HE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/12/2016
Entry Details
Go to US Patent

TargetProstaglandin E2 receptor EP2 subtype(Human)
Fovea Pharmaceuticals

US Patent
LigandPNGBDBM204973(US9249085, I(ag))
Affinity DataEC50: <1nMAssay Description:Human CHO cells expressing the recombinant human prostanoid EP2 receptor were suspended in assay medium (HBSS buffer (Invitrogen) containing 20 mM HE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/12/2016
Entry Details
Go to US Patent

TargetProstaglandin E2 receptor EP2 subtype(Human)
Fovea Pharmaceuticals

US Patent
LigandPNGBDBM204974(US9249085, I(ah))
Affinity DataEC50:  8nMAssay Description:Human CHO cells expressing the recombinant human prostanoid EP2 receptor were suspended in assay medium (HBSS buffer (Invitrogen) containing 20 mM HE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/12/2016
Entry Details
Go to US Patent

TargetProstaglandin E2 receptor EP2 subtype(Human)
Fovea Pharmaceuticals

US Patent
LigandPNGBDBM204975(US9249085, I(ai))
Affinity DataEC50:  35nMAssay Description:Human CHO cells expressing the recombinant human prostanoid EP2 receptor were suspended in assay medium (HBSS buffer (Invitrogen) containing 20 mM HE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/12/2016
Entry Details
Go to US Patent

TargetProstaglandin E2 receptor EP2 subtype(Human)
Fovea Pharmaceuticals

US Patent
LigandPNGBDBM204976(US9249085, I(aj))
Affinity DataEC50:  7nMAssay Description:Human CHO cells expressing the recombinant human prostanoid EP2 receptor were suspended in assay medium (HBSS buffer (Invitrogen) containing 20 mM HE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/12/2016
Entry Details
Go to US Patent

TargetProstaglandin E2 receptor EP2 subtype(Human)
Fovea Pharmaceuticals

US Patent
LigandPNGBDBM204977(US9249085, I(ak) | US9624159, Compound I(ak))
Affinity DataEC50:  2nMAssay Description:Human CHO cells expressing the recombinant human prostanoid EP2 receptor were suspended in assay medium (HBSS buffer (Invitrogen) containing 20 mM HE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/12/2016
Entry Details
Go to US Patent

TargetProstaglandin E2 receptor EP2 subtype(Human)
Fovea Pharmaceuticals

US Patent
LigandPNGBDBM204978(US9249085, I(al) | US9624159, Compound I(al))
Affinity DataEC50:  0.900nMAssay Description:Human CHO cells expressing the recombinant human prostanoid EP2 receptor were suspended in assay medium (HBSS buffer (Invitrogen) containing 20 mM HE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/12/2016
Entry Details
Go to US Patent

TargetProstaglandin E2 receptor EP2 subtype(Human)
Fovea Pharmaceuticals

US Patent
LigandPNGBDBM204979(US9249085, I(am))
Affinity DataEC50:  3nMAssay Description:Human CHO cells expressing the recombinant human prostanoid EP2 receptor were suspended in assay medium (HBSS buffer (Invitrogen) containing 20 mM HE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/12/2016
Entry Details
Go to US Patent

TargetProstaglandin E2 receptor EP2 subtype(Human)
Fovea Pharmaceuticals

US Patent
LigandPNGBDBM204942(US9249085, I(b))
Affinity DataEC50:  28nMAssay Description:Human CHO cells expressing the recombinant human prostanoid EP2 receptor were suspended in assay medium (HBSS buffer (Invitrogen) containing 20 mM HE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/12/2016
Entry Details
Go to US Patent

TargetProstaglandin E2 receptor EP2 subtype(Human)
Fovea Pharmaceuticals

US Patent
LigandPNGBDBM204981(US9249085, I(ao))
Affinity DataEC50:  1nMAssay Description:Human CHO cells expressing the recombinant human prostanoid EP2 receptor were suspended in assay medium (HBSS buffer (Invitrogen) containing 20 mM HE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/12/2016
Entry Details
Go to US Patent

TargetProstaglandin E2 receptor EP2 subtype(Human)
Fovea Pharmaceuticals

US Patent
LigandPNGBDBM204982(US9249085, I(ap))
Affinity DataEC50:  3nMAssay Description:Human CHO cells expressing the recombinant human prostanoid EP2 receptor were suspended in assay medium (HBSS buffer (Invitrogen) containing 20 mM HE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/12/2016
Entry Details
Go to US Patent

TargetProstaglandin E2 receptor EP2 subtype(Human)
Fovea Pharmaceuticals

US Patent
LigandPNGBDBM204983(US9249085, I(aq))
Affinity DataEC50:  2nMAssay Description:Human CHO cells expressing the recombinant human prostanoid EP2 receptor were suspended in assay medium (HBSS buffer (Invitrogen) containing 20 mM HE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/12/2016
Entry Details
Go to US Patent

TargetProstaglandin E2 receptor EP2 subtype(Human)
Fovea Pharmaceuticals

US Patent
LigandPNGBDBM204984(US9249085, I(ar))
Affinity DataEC50:  8nMAssay Description:Human CHO cells expressing the recombinant human prostanoid EP2 receptor were suspended in assay medium (HBSS buffer (Invitrogen) containing 20 mM HE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/12/2016
Entry Details
Go to US Patent

TargetProstaglandin E2 receptor EP2 subtype(Human)
Fovea Pharmaceuticals

US Patent
LigandPNGBDBM204985(US9249085, I(as))
Affinity DataEC50:  11nMAssay Description:Human CHO cells expressing the recombinant human prostanoid EP2 receptor were suspended in assay medium (HBSS buffer (Invitrogen) containing 20 mM HE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/12/2016
Entry Details
Go to US Patent

TargetProstaglandin E2 receptor EP2 subtype(Human)
Fovea Pharmaceuticals

US Patent
LigandPNGBDBM204986(US9249085, I(at) | US9624159, Compound I(at))
Affinity DataEC50:  6nMAssay Description:Human CHO cells expressing the recombinant human prostanoid EP2 receptor were suspended in assay medium (HBSS buffer (Invitrogen) containing 20 mM HE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/12/2016
Entry Details
Go to US Patent

TargetProstaglandin E2 receptor EP2 subtype(Human)
Fovea Pharmaceuticals

US Patent
LigandPNGBDBM204987(US9249085, I(au))
Affinity DataEC50:  15nMAssay Description:Human CHO cells expressing the recombinant human prostanoid EP2 receptor were suspended in assay medium (HBSS buffer (Invitrogen) containing 20 mM HE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/12/2016
Entry Details
Go to US Patent

TargetProstaglandin E2 receptor EP2 subtype(Human)
Fovea Pharmaceuticals

US Patent
LigandPNGBDBM204988(US9249085, I(av))
Affinity DataEC50:  5nMAssay Description:Human CHO cells expressing the recombinant human prostanoid EP2 receptor were suspended in assay medium (HBSS buffer (Invitrogen) containing 20 mM HE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/12/2016
Entry Details
Go to US Patent

TargetProstaglandin E2 receptor EP2 subtype(Human)
Fovea Pharmaceuticals

US Patent
LigandPNGBDBM204989(US9249085, I(aw) | US9624159, Compound I(aw))
Affinity DataEC50:  3nMAssay Description:Human CHO cells expressing the recombinant human prostanoid EP2 receptor were suspended in assay medium (HBSS buffer (Invitrogen) containing 20 mM HE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/12/2016
Entry Details
Go to US Patent

TargetProstaglandin E2 receptor EP2 subtype(Human)
Fovea Pharmaceuticals

US Patent
LigandPNGBDBM204990(US9249085, II(d))
Affinity DataEC50: >300nMAssay Description:Human CHO cells expressing the recombinant human prostanoid EP2 receptor were suspended in assay medium (HBSS buffer (Invitrogen) containing 20 mM HE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/12/2016
Entry Details
Go to US Patent

TargetProstaglandin E2 receptor EP2 subtype(Human)
Fovea Pharmaceuticals

US Patent
LigandPNGBDBM204991(US9249085, I(as) (+ isomer))
Affinity DataEC50:  18nMAssay Description:Human CHO cells expressing the recombinant human prostanoid EP2 receptor were suspended in assay medium (HBSS buffer (Invitrogen) containing 20 mM HE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/12/2016
Entry Details
Go to US Patent

TargetProstaglandin E2 receptor EP2 subtype(Human)
Fovea Pharmaceuticals

US Patent
LigandPNGBDBM204992(US9249085, CP-544326)
Affinity DataEC50:  46nMAssay Description:Human CHO cells expressing the recombinant human prostanoid EP2 receptor were suspended in assay medium (HBSS buffer (Invitrogen) containing 20 mM HE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/12/2016
Entry Details
Go to US Patent

TargetProstaglandin E2 receptor EP2 subtype(Human)
Fovea Pharmaceuticals

US Patent
LigandPNGBDBM204966(US9249085, I(z))
Affinity DataEC50:  4nMAssay Description:Human CHO cells expressing the recombinant human prostanoid EP2 receptor were suspended in assay medium (HBSS buffer (Invitrogen) containing 20 mM HE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/12/2016
Entry Details
Go to US Patent

TargetProstaglandin E2 receptor EP2 subtype(Human)
Fovea Pharmaceuticals

US Patent
LigandPNGBDBM204941(US9249085, I(a))
Affinity DataEC50:  110nMAssay Description:Human CHO cells expressing the recombinant human prostanoid EP2 receptor were suspended in assay medium (HBSS buffer (Invitrogen) containing 20 mM HE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/12/2016
Entry Details
Go to US Patent

TargetProstaglandin E2 receptor EP2 subtype(Human)
Fovea Pharmaceuticals

US Patent
LigandPNGBDBM204943(US9249085, I(c))
Affinity DataEC50:  69nMAssay Description:Human CHO cells expressing the recombinant human prostanoid EP2 receptor were suspended in assay medium (HBSS buffer (Invitrogen) containing 20 mM HE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/12/2016
Entry Details
Go to US Patent

TargetProstaglandin E2 receptor EP2 subtype(Human)
Fovea Pharmaceuticals

US Patent
LigandPNGBDBM204944(US9249085, I(d))
Affinity DataEC50:  35nMAssay Description:Human CHO cells expressing the recombinant human prostanoid EP2 receptor were suspended in assay medium (HBSS buffer (Invitrogen) containing 20 mM HE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/12/2016
Entry Details
Go to US Patent

TargetProstaglandin E2 receptor EP2 subtype(Human)
Fovea Pharmaceuticals

US Patent
LigandPNGBDBM204945(US9249085, I(e))
Affinity DataEC50:  160nMAssay Description:Human CHO cells expressing the recombinant human prostanoid EP2 receptor were suspended in assay medium (HBSS buffer (Invitrogen) containing 20 mM HE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/12/2016
Entry Details
Go to US Patent

TargetProstaglandin E2 receptor EP2 subtype(Human)
Fovea Pharmaceuticals

US Patent
LigandPNGBDBM204946(US9249085, I(f))
Affinity DataEC50:  160nMAssay Description:Human CHO cells expressing the recombinant human prostanoid EP2 receptor were suspended in assay medium (HBSS buffer (Invitrogen) containing 20 mM HE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/12/2016
Entry Details
Go to US Patent

TargetProstaglandin E2 receptor EP2 subtype(Human)
Fovea Pharmaceuticals

US Patent
LigandPNGBDBM204947(US9249085, I(g))
Affinity DataEC50:  55nMAssay Description:Human CHO cells expressing the recombinant human prostanoid EP2 receptor were suspended in assay medium (HBSS buffer (Invitrogen) containing 20 mM HE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/12/2016
Entry Details
Go to US Patent

TargetProstaglandin E2 receptor EP2 subtype(Human)
Fovea Pharmaceuticals

US Patent
LigandPNGBDBM204948(US9249085, I(h))
Affinity DataEC50:  13nMAssay Description:Human CHO cells expressing the recombinant human prostanoid EP2 receptor were suspended in assay medium (HBSS buffer (Invitrogen) containing 20 mM HE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/12/2016
Entry Details
Go to US Patent

TargetProstaglandin E2 receptor EP2 subtype(Human)
Fovea Pharmaceuticals

US Patent
LigandPNGBDBM204949(US9249085, I(i))
Affinity DataEC50:  99nMAssay Description:Human CHO cells expressing the recombinant human prostanoid EP2 receptor were suspended in assay medium (HBSS buffer (Invitrogen) containing 20 mM HE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/12/2016
Entry Details
Go to US Patent

TargetProstaglandin E2 receptor EP2 subtype(Human)
Fovea Pharmaceuticals

US Patent
LigandPNGBDBM204950(US9249085, I(j))
Affinity DataEC50:  26nMAssay Description:Human CHO cells expressing the recombinant human prostanoid EP2 receptor were suspended in assay medium (HBSS buffer (Invitrogen) containing 20 mM HE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/12/2016
Entry Details
Go to US Patent

TargetProstaglandin E2 receptor EP2 subtype(Human)
Fovea Pharmaceuticals

US Patent
LigandPNGBDBM204951(US9249085, I(k) | US9624159, Compound I(k))
Affinity DataEC50:  73nMAssay Description:Human CHO cells expressing the recombinant human prostanoid EP2 receptor were suspended in assay medium (HBSS buffer (Invitrogen) containing 20 mM HE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/12/2016
Entry Details
Go to US Patent

TargetProstaglandin E2 receptor EP2 subtype(Human)
Fovea Pharmaceuticals

US Patent
LigandPNGBDBM204952(US9249085, I(l))
Affinity DataEC50:  24nMAssay Description:Human CHO cells expressing the recombinant human prostanoid EP2 receptor were suspended in assay medium (HBSS buffer (Invitrogen) containing 20 mM HE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/12/2016
Entry Details
Go to US Patent

TargetProstaglandin E2 receptor EP2 subtype(Human)
Fovea Pharmaceuticals

US Patent
LigandPNGBDBM204953(US9249085, I(m))
Affinity DataEC50:  10nMAssay Description:Human CHO cells expressing the recombinant human prostanoid EP2 receptor were suspended in assay medium (HBSS buffer (Invitrogen) containing 20 mM HE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/12/2016
Entry Details
Go to US Patent

TargetProstaglandin E2 receptor EP2 subtype(Human)
Fovea Pharmaceuticals

US Patent
LigandPNGBDBM204955(US9249085, I(o))
Affinity DataEC50:  34nMAssay Description:Human CHO cells expressing the recombinant human prostanoid EP2 receptor were suspended in assay medium (HBSS buffer (Invitrogen) containing 20 mM HE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/12/2016
Entry Details
Go to US Patent

TargetProstaglandin E2 receptor EP2 subtype(Human)
Fovea Pharmaceuticals

US Patent
LigandPNGBDBM204967(US9249085, I(aa) | US9624159, Compound I(aa))
Affinity DataEC50:  3nMAssay Description:Human CHO cells expressing the recombinant human prostanoid EP2 receptor were suspended in assay medium (HBSS buffer (Invitrogen) containing 20 mM HE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/12/2016
Entry Details
Go to US Patent

TargetProstaglandin E2 receptor EP2 subtype(Human)
Fovea Pharmaceuticals

US Patent
LigandPNGBDBM204965(US9249085, I(y))
Affinity DataEC50:  130nMAssay Description:Human CHO cells expressing the recombinant human prostanoid EP2 receptor were suspended in assay medium (HBSS buffer (Invitrogen) containing 20 mM HE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/12/2016
Entry Details
Go to US Patent

TargetProstaglandin E2 receptor EP2 subtype(Human)
Fovea Pharmaceuticals

US Patent
LigandPNGBDBM204964(US9249085, I(x))
Affinity DataEC50:  27nMAssay Description:Human CHO cells expressing the recombinant human prostanoid EP2 receptor were suspended in assay medium (HBSS buffer (Invitrogen) containing 20 mM HE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/12/2016
Entry Details
Go to US Patent

TargetProstaglandin E2 receptor EP2 subtype(Human)
Fovea Pharmaceuticals

US Patent
LigandPNGBDBM204963(US9249085, I(w))
Affinity DataEC50:  14nMAssay Description:Human CHO cells expressing the recombinant human prostanoid EP2 receptor were suspended in assay medium (HBSS buffer (Invitrogen) containing 20 mM HE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/12/2016
Entry Details
Go to US Patent

TargetProstaglandin E2 receptor EP2 subtype(Human)
Fovea Pharmaceuticals

US Patent
LigandPNGBDBM204962(US9249085, I(v))
Affinity DataEC50:  2nMAssay Description:Human CHO cells expressing the recombinant human prostanoid EP2 receptor were suspended in assay medium (HBSS buffer (Invitrogen) containing 20 mM HE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/12/2016
Entry Details
Go to US Patent

TargetProstaglandin E2 receptor EP2 subtype(Human)
Fovea Pharmaceuticals

US Patent
LigandPNGBDBM204961(US9249085, I(u))
Affinity DataEC50:  9nMAssay Description:Human CHO cells expressing the recombinant human prostanoid EP2 receptor were suspended in assay medium (HBSS buffer (Invitrogen) containing 20 mM HE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/12/2016
Entry Details
Go to US Patent

TargetProstaglandin E2 receptor EP2 subtype(Human)
Fovea Pharmaceuticals

US Patent
LigandPNGBDBM204960(US9249085, I(t))
Affinity DataEC50:  17nMAssay Description:Human CHO cells expressing the recombinant human prostanoid EP2 receptor were suspended in assay medium (HBSS buffer (Invitrogen) containing 20 mM HE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/12/2016
Entry Details
Go to US Patent

TargetProstaglandin E2 receptor EP2 subtype(Human)
Fovea Pharmaceuticals

US Patent
LigandPNGBDBM204959(US9249085, I(s))
Affinity DataEC50:  17nMAssay Description:Human CHO cells expressing the recombinant human prostanoid EP2 receptor were suspended in assay medium (HBSS buffer (Invitrogen) containing 20 mM HE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/12/2016
Entry Details
Go to US Patent

TargetProstaglandin E2 receptor EP2 subtype(Human)
Fovea Pharmaceuticals

US Patent
LigandPNGBDBM204958(US9249085, I(r) | US9624159, Compound I(r))
Affinity DataEC50:  45nMAssay Description:Human CHO cells expressing the recombinant human prostanoid EP2 receptor were suspended in assay medium (HBSS buffer (Invitrogen) containing 20 mM HE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/12/2016
Entry Details
Go to US Patent

TargetProstaglandin E2 receptor EP2 subtype(Human)
Fovea Pharmaceuticals

US Patent
LigandPNGBDBM204957(US9249085, I(q))
Affinity DataEC50:  18nMAssay Description:Human CHO cells expressing the recombinant human prostanoid EP2 receptor were suspended in assay medium (HBSS buffer (Invitrogen) containing 20 mM HE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/12/2016
Entry Details
Go to US Patent

Displayed 1 to 50 (of 61 total ) | Next | Last >>
Jump to: